DRIPCALC V2 LAUNCH SALE - 40% OFF

NEW Dividend Portfolio Tracker (DRIPTracker) is Now Live!

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Innoviva, Inc. INVA | NASDAQ

$21.06 $0.15 | 0.72%

TREND SIGNAL: Signal available — unlock to view

Signal available — unlock to view

|2026-10-20

Next Earnings: Nov 04, 2026

Add to favoritesFavorite

Company Overview:

Market Cap: $1.52B

Trailing PE: 5.1x

FWD PE *: 9.8x

Payout Ratio (TTM): 0.0%

52-Week Range: $17.45 - $25.15

* Forward PE is based on street estimates.

10 Year INVA Performance Metrics:

Total Return (with DRIP): 110.0% (7.70% CAGR)

Total Return (no DRIP): 110.0% (7.70% CAGR)

Share Price: 110.0% (7.70% CAGR)

Yield on Cost (with DRIP): 9.97%

Total Invested: $10,000

Total Value (with DRIP): $20,997

Total Return $ (with DRIP): $10,997

Dividend Increase: N/A (0.00% CAGR)

Dividend Yield (FWD): 4.75% ($1.00)

INVA 10-yr Total Return ($10K invested)

1M 3M 6M YTD 1Y 3Y 5Y 10Y

INVA Share Price

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

INVA Price CAGR:1Y: 14.77%2Y: 2.69%5Y: 5.34%10Y: 7.70%

INVA Dividend Charts

INVA - Dividends

INVA Dividend CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - Dividend Payout Ratio

INVA Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - Dividend to Free Cash Flow Ratio

INVA Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

INVA Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

INVA - Revenue

INVA Revenue CAGR:1Y: 19.25%2Y: 7.57%5Y: 3.48%10Y: 13.92%

INVA - Earnings Per Share (EPS)

INVA EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - Net Income

🔓 See the full chart40% off right now · 7-day free trial

INVA Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

INVA EBITDA CAGR:1Y: 218.85%2Y: 0.00%5Y: 13.10%10Y: 25.42%

INVA - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

INVA Free Cash Flow CAGR:1Y: 16.95%2Y: 8.58%5Y: -9.44%10Y: 15.26%

INVA - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

INVA Free Cash Flow / Share CAGR:1Y: 0.13%2Y: 0.20%5Y: -6.01%10Y: 20.17%

INVA - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

INVA Operating Income CAGR:1Y: 0.00%2Y: -3.57%5Y: -12.03%10Y: 6.99%

INVA - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

INVA Gross Profit CAGR:1Y: 1.03%2Y: 3.27%5Y: -2.10%10Y: 10.93%

INVA - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

INVA Shares Outstanding CAGR:1Y: -13.06%2Y: 8.36%5Y: -6.11%10Y: -5.13%

INVA - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

INVA Share Buybacks CAGR:1Y: 128,687.50%2Y: 143.13%5Y: -39.90%10Y: 4.92%

INVA - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

INVA Stock-Based Comp CAGR:1Y: 95.83%2Y: 69.91%5Y: 58.78%10Y: 5.26%

INVA - Expenses

🔓 See the full chart40% off right now · 7-day free trial

INVA Expenses CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 48.91%

INVA - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

INVA - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

INVA - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

INVA - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

INVA - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

INVA - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

INVA - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

INVA Revenue CAGR:1Y: 19.25%2Y: 7.57%5Y: 3.48%10Y: 13.92%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

INVA - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

INVA Actual Revenue CAGR:1Y: 19.25%2Y: 7.57%5Y: 3.48%10Y: 13.92%

INVA - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

INVA Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

INVA Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

INVA Actual EBITDA CAGR:1Y: 218.85%2Y: 0.00%5Y: 13.10%10Y: 25.42%

Ratios, Profit Margins & Return on Capital:

INVA - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

INVA Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

INVA Gross Profit Margin CAGR:1Y: -15.28%2Y: -4.00%5Y: -5.39%10Y: -2.62%

INVA - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

INVA Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

INVA - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

INVA Price To Sales Ratio CAGR:1Y: 10.71%2Y: 18.18%5Y: 3.46%10Y: -9.08%

INVA - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

INVA Return on Capital Employed CAGR:1Y: 0.00%2Y: -18.01%5Y: -24.25%10Y: -7.96%

INVA - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

INVA Return on Invested Capital CAGR:1Y: 0.00%2Y: -23.30%5Y: -25.05%10Y: 4.11%

INVA Dividends Info:

Annual Dividend: $1

Forward Yield: 4.75%

Ex-Dividend Date: 2015-09-08

Lifetime Dividends / Share: $1.25

INVA Dividend History: Dates, Payments & Yield list

Below is a schedule of all INVA dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield

Ex-Date	Payment Date	Amount	Yield	Forward Yield	Price on Ex-Date
09/08/2015	09/30/2015	$0.250	7.39%	13.93%	$7.18
06/10/2015	06/30/2015	$0.250	5.63%	5.64%	$17.74
03/10/2015	03/31/2015	$0.250	5.23%	6.57%	$15.22
11/21/2014	12/23/2014	$0.250	7.49%	7.3%	$13.70
08/26/2014	09/18/2014	$0.250	4.58%	5.71%	$17.50

Projected Future Returns & Dividends for INVA

Based on past 10-year performance, here are INVA growth metrics:

Share price CAGR of +7.7%
Dividend CAGR of +0%

Using INVA CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	INVA (DRIP)	INVA - No DRIP
Current Price	$21.06	$21.06
Start Shares	474.83	474.83
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	547.07	474.83
Dividends Payment	$0.25	$0.25
Annual Dividends	$547	$475
Yield on cost	5.47%	4.75%
Share Price	$21.06	$21.06
Total Dividends	$1,521	$1,425
Final Value	$11,521	$11,425

Estimated Future Value + Dividends - INVA

NOTE: Above numbers are our estimate based on INVA's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Innoviva, Inc. (INVA) had its IPO on 2004-10-05, and is traded on NASDAQ stock exchange.

Innoviva, Inc. functions as a pharmaceutical company, concentrating on the worldwide creation and marketing of medical treatments. Its current product lineup prominently includes several once-daily combination therapies: RELVAR/BREO ELLIPTA, which integrates vilanterol (a long-acting beta2 agonist, or LABA) with fluticasone furoate (an inhaled corticosteroid, or ICS); ANORO ELLIPTA, a medication that pairs umeclidinium bromide (a long-acting muscarinic antagonist, or LAMA) with vilanterol (LABA); and TRELEGY ELLIPTA, a comprehensive treatment combining an ICS, LAMA, and LABA. The company has forged a key strategic alliance with Sarissa Capital Management LP. Moreover, Innoviva collaborates with Glaxo Group Limited under an agreement focused on the development and commercialization of daily LABA-based products designed to treat chronic obstructive pulmonary disease and asthma. Founded in 1996, the corporation was initially known as Theravance, Inc., before officially changing its name to Innoviva, Inc. in January 2016. Its primary operational base is situated in Burlingame, California.

INVA website: https://www.inva.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Most Popular

PREMIUM

$288 ($24/mo) $172.80/yr ($14.40/mo)

7-day free trial

Everything in Pro
YieldMax PNL Tracker
YieldMax NAV Erosion Alerts
YM ETFs Trend Signals
9/21 EMA Trend Signals
Stocks Dashboard

Try it free for 7 days

Combined 55% Lifetime Discount

ULTRA

$576 ($48/mo) $345.60/yr ($28.80/mo)

7-day free trial

Everything in Premium
15min & 1hr Intraday Signals
Group & weekly ETF estimates
YouTuber Mode
Trades summary + CSV export
Priority data & support

Try it free for 7 days

Combined 55% Lifetime Discount

Loading signals…

DCF Model — INVA

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $21.06

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →

× Free Portfolio Tracker

Own INVA? See every dividend it's paid you

Add your INVA shares to a free account and every payment you've received is listed — dated, in dollars — with reinvested shares counted and monthly totals. Room for 4 more stocks.

✓Every INVA dividend you've received, dated, with the amount
✓Reinvested (DRIP) shares counted for you
✓Monthly totals across up to 5 stocks

Add INVA free →

Free plan · up to 5 holdings